Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :1983
Small font sizeDefault font sizeIncrease font size
Navigate Here
  »   My Preferences 
  »   Manuscript submission

 


This article has been cited by
1Pharmacological Management of Chemotherapy-Induced Nausea and Vomiting in Children with Cancer
M.G. Cefalo,A. Ruggiero,P. Maurizi,G. Attinŕ,A. Arlotta,R. Riccardi
Journal of Chemotherapy.2009;21(6)605
[DOI]
2Application of analytical quality by design principles for the determination of alkyl p -toluenesulfonates impurities in Aprepitant by HPLC. Validation using total-error concept
Constantinos K. Zacharis,Elli Vastardi
Journal of Pharmaceutical and Biomedical Analysis.2018;150(6)152
[DOI]
3Complementary Pharmacokinetic Profiles of Netupitant and Palonosetron Support the Rationale for Their Oral Fixed Combination for the Prevention of Chemotherapy-Induced Nausea and Vomiting
James Gilmore,Alberto Bernareggi
The Journal of Clinical Pharmacology.2019;59(4)472
[DOI]
4Doxorubicin-Induced Myocardial Fibrosis Involves the Neurokinin-1 Receptor and Direct Effects on Cardiac Fibroblasts
Scott P. Levick,David R. Soto-Pantoja,Jianli Bi,W. Gregory Hundley,Alexander Widiapradja,Edward J. Manteufel,Tancia W. Bradshaw,Giselle C. Meléndez
Heart, Lung and Circulation.2019;28(10)1598
[DOI]
5Treatment of nausea with innovative antiemetics
Yuki Fujii,Hanae Ida,Tatsushi Shimokuni,Fumihiko Haraguchi
Expert Review of Quality of Life in Cancer Care.2017;2(2)109
[DOI]
6Pharmacological Characterization of T-2328, 2-Fluoro-4'-methoxy-3'-[[[(2S,3S)-2-phenyl-3-piperidinyl]amino]methyl]-[1,1'-biphenyl]-4-carbonitrile Dihydrochloride, as a Brain-Penetrating Antagonist of Tachykinin NK1 Receptor
Yumi Watanabe,Hidetoshi Asai,Taketoshi Ishii,Satoko Kiuchi,Masahito Okamoto,Hiroyuki Taniguchi,Masaaki Nagasaki,Akira Saito
Journal of Pharmacological Sciences.2008;106(1)121
[DOI]
7Current pharmacotherapy for chemotherapy-induced nausea and vomiting in cancer patients
Michelle C Janelsins,Mohamedtaki A Tejani,Charles Kamen,Anita R Peoples,Karen M Mustian,Gary R Morrow
Expert Opinion on Pharmacotherapy.2013;14(6)757
[DOI]
8Neurokinin-1 receptor (NK1R) inhibition sensitizes APL cells to anti-tumor effect of arsenic trioxide via restriction of NF-?B axis: Shedding new light on resistance to Aprepitant
Davood Bashash,Ava Safaroghli-Azar,Samaneh Bayati,Elham Razani,Atieh Pourbagheri-Sigaroodi,Arshia Gharehbaghian,Majid Momeny,Maryam Sanjadi,Mostafa Rezaie-Tavirani,Seyed H. Ghaffari
The International Journal of Biochemistry & Cell Biology.2018;103(6)105
[DOI]
9Use of high-dose cisplatin with aprepitant in an outpatient setting
N. FURUKAWA,R. KAWAGUCHI,H. KOBAYASHI
European Journal of Cancer Care.2012;21(4)436
[DOI]
  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  © 2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow